The Role of Respiratory Syncytial Virus Infection in the Hospitalization and Mortality of Adults with Congestive Heart Failure in Spain, 2018–2022
(1) Background: Heart failure (HF) is a growing health concern, with decompensations being a major cause of hospital admissions. Respiratory syncytial virus (RSV) infection can trigger HF exacerbations, increasing morbidity and mortality. This study analyzed hospitalizations for HF with RSV infectio...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Viruses |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/17/4/516 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850180252326690816 |
|---|---|
| author | Rosa María Gómez-García Rodrigo Jiménez-García Ana López-de-Andrés Valentín Hernández-Barrera Ana Jimenez-Sierra Natividad Cuadrado-Corrales José Javier Zamorano-León David Carabantes-Alarcón Andrés Bodas-Pinedo Javier De-Miguel-Díez |
| author_facet | Rosa María Gómez-García Rodrigo Jiménez-García Ana López-de-Andrés Valentín Hernández-Barrera Ana Jimenez-Sierra Natividad Cuadrado-Corrales José Javier Zamorano-León David Carabantes-Alarcón Andrés Bodas-Pinedo Javier De-Miguel-Díez |
| author_sort | Rosa María Gómez-García |
| collection | DOAJ |
| description | (1) Background: Heart failure (HF) is a growing health concern, with decompensations being a major cause of hospital admissions. Respiratory syncytial virus (RSV) infection can trigger HF exacerbations, increasing morbidity and mortality. This study analyzed hospitalizations for HF with RSV infection in Spain from 2018 to 2022 using data from the Spanish Hospital Discharge Database. (2) Methods: We included patients aged ≥40 years with a diagnosis of HF, selecting a matched control group without RSV infection based on the HF diagnostic code position, year of admission, sex, and age. (3) Results: Of 424,413 HF hospitalizations, 0.47% (1988) involved RSV infection. Hospitalizations for HF with RSV increased over time, except for a decline in 2020–2021. ICU admissions and hospital length of stay decreased, but in-hospital mortality and costs remained unchanged. Patients with RSV had fewer comorbidities than those without RSV but experienced a higher mortality, more frequent non-invasive ventilation, longer hospital stays, and greater costs. Factors linked to higher mortality included advanced age, myocardial infarction, SARS-CoV-2 coinfection, and oxygen therapy dependence. RSV infection was independently associated with increased in-hospital mortality. (4) Conclusions: These findings highlight the need for early RSV detection in HF patients to implement preventive measures and reduce severe disease outcomes. |
| format | Article |
| id | doaj-art-3c8e8fbc4ca2422b8469d6b81928a16f |
| institution | OA Journals |
| issn | 1999-4915 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Viruses |
| spelling | doaj-art-3c8e8fbc4ca2422b8469d6b81928a16f2025-08-20T02:18:15ZengMDPI AGViruses1999-49152025-04-0117451610.3390/v17040516The Role of Respiratory Syncytial Virus Infection in the Hospitalization and Mortality of Adults with Congestive Heart Failure in Spain, 2018–2022Rosa María Gómez-García0Rodrigo Jiménez-García1Ana López-de-Andrés2Valentín Hernández-Barrera3Ana Jimenez-Sierra4Natividad Cuadrado-Corrales5José Javier Zamorano-León6David Carabantes-Alarcón7Andrés Bodas-Pinedo8Javier De-Miguel-Díez9Respiratory Care Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense de Madrid, 28007 Madrid, SpainDepartment of Public Health & Maternal and Child Health, Faculty of Medicine, Universidad Complutense de Madrid, 28040 Madrid, SpainDepartment of Public Health & Maternal and Child Health, Faculty of Pharmacy, Universidad Complutense de Madrid, 28040 Madrid, SpainPreventive Medicine and Public Health Teaching and Research Unit, Health Sciences Faculty, Rey Juan Carlos University, 28922 Alcorcón, SpainFaculty of Medicine, Universidad San Pablo Ceu, 28668 Madrid, SpainDepartment of Public Health & Maternal and Child Health, Faculty of Medicine, Universidad Complutense de Madrid, 28040 Madrid, SpainDepartment of Public Health & Maternal and Child Health, Faculty of Medicine, Universidad Complutense de Madrid, 28040 Madrid, SpainDepartment of Public Health & Maternal and Child Health, Faculty of Medicine, Universidad Complutense de Madrid, 28040 Madrid, SpainDepartment of Public Health & Maternal and Child Health, Faculty of Medicine, Universidad Complutense de Madrid, 28040 Madrid, SpainRespiratory Care Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Universidad Complutense de Madrid, 28007 Madrid, Spain(1) Background: Heart failure (HF) is a growing health concern, with decompensations being a major cause of hospital admissions. Respiratory syncytial virus (RSV) infection can trigger HF exacerbations, increasing morbidity and mortality. This study analyzed hospitalizations for HF with RSV infection in Spain from 2018 to 2022 using data from the Spanish Hospital Discharge Database. (2) Methods: We included patients aged ≥40 years with a diagnosis of HF, selecting a matched control group without RSV infection based on the HF diagnostic code position, year of admission, sex, and age. (3) Results: Of 424,413 HF hospitalizations, 0.47% (1988) involved RSV infection. Hospitalizations for HF with RSV increased over time, except for a decline in 2020–2021. ICU admissions and hospital length of stay decreased, but in-hospital mortality and costs remained unchanged. Patients with RSV had fewer comorbidities than those without RSV but experienced a higher mortality, more frequent non-invasive ventilation, longer hospital stays, and greater costs. Factors linked to higher mortality included advanced age, myocardial infarction, SARS-CoV-2 coinfection, and oxygen therapy dependence. RSV infection was independently associated with increased in-hospital mortality. (4) Conclusions: These findings highlight the need for early RSV detection in HF patients to implement preventive measures and reduce severe disease outcomes.https://www.mdpi.com/1999-4915/17/4/516heart failurerespiratory syncytial virushospitalizationsmortalitycostsSpain |
| spellingShingle | Rosa María Gómez-García Rodrigo Jiménez-García Ana López-de-Andrés Valentín Hernández-Barrera Ana Jimenez-Sierra Natividad Cuadrado-Corrales José Javier Zamorano-León David Carabantes-Alarcón Andrés Bodas-Pinedo Javier De-Miguel-Díez The Role of Respiratory Syncytial Virus Infection in the Hospitalization and Mortality of Adults with Congestive Heart Failure in Spain, 2018–2022 Viruses heart failure respiratory syncytial virus hospitalizations mortality costs Spain |
| title | The Role of Respiratory Syncytial Virus Infection in the Hospitalization and Mortality of Adults with Congestive Heart Failure in Spain, 2018–2022 |
| title_full | The Role of Respiratory Syncytial Virus Infection in the Hospitalization and Mortality of Adults with Congestive Heart Failure in Spain, 2018–2022 |
| title_fullStr | The Role of Respiratory Syncytial Virus Infection in the Hospitalization and Mortality of Adults with Congestive Heart Failure in Spain, 2018–2022 |
| title_full_unstemmed | The Role of Respiratory Syncytial Virus Infection in the Hospitalization and Mortality of Adults with Congestive Heart Failure in Spain, 2018–2022 |
| title_short | The Role of Respiratory Syncytial Virus Infection in the Hospitalization and Mortality of Adults with Congestive Heart Failure in Spain, 2018–2022 |
| title_sort | role of respiratory syncytial virus infection in the hospitalization and mortality of adults with congestive heart failure in spain 2018 2022 |
| topic | heart failure respiratory syncytial virus hospitalizations mortality costs Spain |
| url | https://www.mdpi.com/1999-4915/17/4/516 |
| work_keys_str_mv | AT rosamariagomezgarcia theroleofrespiratorysyncytialvirusinfectioninthehospitalizationandmortalityofadultswithcongestiveheartfailureinspain20182022 AT rodrigojimenezgarcia theroleofrespiratorysyncytialvirusinfectioninthehospitalizationandmortalityofadultswithcongestiveheartfailureinspain20182022 AT analopezdeandres theroleofrespiratorysyncytialvirusinfectioninthehospitalizationandmortalityofadultswithcongestiveheartfailureinspain20182022 AT valentinhernandezbarrera theroleofrespiratorysyncytialvirusinfectioninthehospitalizationandmortalityofadultswithcongestiveheartfailureinspain20182022 AT anajimenezsierra theroleofrespiratorysyncytialvirusinfectioninthehospitalizationandmortalityofadultswithcongestiveheartfailureinspain20182022 AT natividadcuadradocorrales theroleofrespiratorysyncytialvirusinfectioninthehospitalizationandmortalityofadultswithcongestiveheartfailureinspain20182022 AT josejavierzamoranoleon theroleofrespiratorysyncytialvirusinfectioninthehospitalizationandmortalityofadultswithcongestiveheartfailureinspain20182022 AT davidcarabantesalarcon theroleofrespiratorysyncytialvirusinfectioninthehospitalizationandmortalityofadultswithcongestiveheartfailureinspain20182022 AT andresbodaspinedo theroleofrespiratorysyncytialvirusinfectioninthehospitalizationandmortalityofadultswithcongestiveheartfailureinspain20182022 AT javierdemigueldiez theroleofrespiratorysyncytialvirusinfectioninthehospitalizationandmortalityofadultswithcongestiveheartfailureinspain20182022 AT rosamariagomezgarcia roleofrespiratorysyncytialvirusinfectioninthehospitalizationandmortalityofadultswithcongestiveheartfailureinspain20182022 AT rodrigojimenezgarcia roleofrespiratorysyncytialvirusinfectioninthehospitalizationandmortalityofadultswithcongestiveheartfailureinspain20182022 AT analopezdeandres roleofrespiratorysyncytialvirusinfectioninthehospitalizationandmortalityofadultswithcongestiveheartfailureinspain20182022 AT valentinhernandezbarrera roleofrespiratorysyncytialvirusinfectioninthehospitalizationandmortalityofadultswithcongestiveheartfailureinspain20182022 AT anajimenezsierra roleofrespiratorysyncytialvirusinfectioninthehospitalizationandmortalityofadultswithcongestiveheartfailureinspain20182022 AT natividadcuadradocorrales roleofrespiratorysyncytialvirusinfectioninthehospitalizationandmortalityofadultswithcongestiveheartfailureinspain20182022 AT josejavierzamoranoleon roleofrespiratorysyncytialvirusinfectioninthehospitalizationandmortalityofadultswithcongestiveheartfailureinspain20182022 AT davidcarabantesalarcon roleofrespiratorysyncytialvirusinfectioninthehospitalizationandmortalityofadultswithcongestiveheartfailureinspain20182022 AT andresbodaspinedo roleofrespiratorysyncytialvirusinfectioninthehospitalizationandmortalityofadultswithcongestiveheartfailureinspain20182022 AT javierdemigueldiez roleofrespiratorysyncytialvirusinfectioninthehospitalizationandmortalityofadultswithcongestiveheartfailureinspain20182022 |